Results 151 to 160 of about 21,319,883 (205)

Isolation of Phytoecdysteroids: Ajugasterone C and 20-Hydroxyecdysone, from <i>Sida alba</i> Linn. [PDF]

open access: yesACS Omega
Ezennaka CN   +8 more
europepmc   +1 more source

Preclinical evaluation of multivalent vaccine combinations against <i>Shigella</i> and <i>Salmonella</i> infections. [PDF]

open access: yesFront Immunol
Di Benedetto R   +13 more
europepmc   +1 more source

The Burden and Genomic Characterization of Shigella -Associated Diarrhea in Children Under Five in Lusaka, Zambia: A Prospective Cohort Study

open access: yes
Chibuye M   +15 more
europepmc   +1 more source

Identification of a putative pathogenicity island in Shigella flexneri using subtractive hybridisation of the S. flexneri and Escherichia coli genomes. [PDF]

open access: yesFEMS Microbiology Letters, 2002
The genetic differences between the human pathogen, Shigella flexneri, and the non-pathogenic Escherichia coli were investigated in an attempt to identify pathogenicity islands (PAIs) in the S. flexneri genome. Genomic subtraction identified a large unique region of DNA which was present in S. flexneri serotype 2a but absent from E. coli K-12.
Naresh Verma, John C Walker
exaly   +4 more sources

Antibacterial Activity of Epigallocatechin Gallate (EGCG) against Shigella flexneri

open access: yesInternational Journal of Environmental Research and Public Health, 2023
Shigella flexneri (S. flexneri), a major intestinal pathogen, is a global public health concern. The biofilms formed by S. flexneri threaten environmental safety, since they could promote the danger of environmental contamination and strengthen the ...
Zheng Ji
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Auxotrophic live oral Shigella flexneri vaccine protects monkeys against challenge with S. flexneri of different serotypes

Vaccine, 1992
The aromatic-dependent live Shigella flexneri Y strain SFL114, attenuated by a Tn10-inactivated aroD gene, was given as an oral vaccine to 14 Macaca fascicularis monkeys. A significant clinical attenuation of SFL114 was seen (p = 0.0058) as all vaccinated monkeys tolerated 2 x 10(10)-1 x 10(11) bacteria of SFL114, whereas four out of seven monkeys ...
A, Kärnell, H, Sweiha, A A, Lindberg
openaire   +2 more sources

Home - About - Disclaimer - Privacy